Jiqiang Li
- Epidemiology top 10%
- Hepatology top 5%
- Molecular Biology
- Infectious Diseases
- Complementary and alternative medicine top 10%
- Topics
- COVID-19 Clinical Research Studies (4 papers)Liver Disease Diagnosis and Treatment (4 papers)Influenza Virus Research Studies (3 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Jiqiang Li
35 papers receiving 680 citations
Peers
Comparison fields: 5 of 114
- Epidemiology 291
- Hepatology 213
- Molecular Biology 118
- Infectious Diseases 83
- Complementary and alternative medicine 53
Countries citing papers authored by Jiqiang Li
This map shows the geographic impact of Jiqiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiqiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiqiang Li more than expected).
Fields of papers citing papers by Jiqiang Li
This network shows the impact of papers produced by Jiqiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiqiang Li. The network helps show where Jiqiang Li may publish in the future.
Co-authorship network of co-authors of Jiqiang Li
This figure shows the co-authorship network connecting the top 25 collaborators of Jiqiang Li. A scholar is included among the top collaborators of Jiqiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiqiang Li. Jiqiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 6 | |
| 7 | 16 | |
| 8 | 25 | |
| 9 | 23 | |
| 10 | 2 | |
| 11 | 36 | |
| 12 | 19 | |
| 13 | 17 | |
| 14 | 45 | |
| 15 | 5 | |
| 16 | 37 | |
| 17 | 52 | |
| 18 | 2 | |
| 19 | 139 | |
| 20 | 69 |
About Jiqiang Li
Jiqiang Li is a scholar working on Hepatology, Metals and Alloys and Complementary and alternative medicine, having authored 37 papers that have together received 699 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Influenza Virus Research Studies (3 papers). The work is most often cited by research in Hepatology (213 citations), Epidemiology (291 citations) and Complementary and alternative medicine (53 citations). Jiqiang Li has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Lungen Lu, Jiyao Wang, Minde Zeng, Xia-qiu Zhou, Cheng‐Wei Chen, Xiong Cai, Yimin Mao, Chunfang Gao, Chengzhong Li and Mobin Wan. Their work appears in journals such as Hepatology, Frontiers in Immunology and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.